Clinical Trial 42251

share

Durham, NC 27704


Study Summary:

The M16-063 clinical research study needs people with rheumatoid arthritis who have tried biologic and synthetic DMARDs,* but still have symptoms. DMARDs include drugs like adalimumab, infliximab, certolizumab, golimumab, tocilizumab, abatacept, etanercept, and rituximab



You may qualify for this study if you:

-Are at least 18 years of age Have had rheumatoid arthritis for at least 3 months
-Have at least 6 tender and 6 swollen joints
-Have tried biologic and synthetic DMARDs* for your rheumatoid arthritis

* If you aren’t sure if that’s you, but you’ve taken two or more types of medication for your rheumatoid arthritis and still have swollen and tender joints, ask your doctor or contact us to find out more.


Qualified Participants May Receive:

Qualified participants will receive:

  • Study-related medication at no cost
  • Study-related medical exams at no cost
  • Compensation for time and travel


Study is Available At:

M3-Emerging Medical Research, LLC
120 William Penn Plaza
Durham, NC 27704
View Clinic Location

 


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.